文献速递主动脉疾病

编辑推荐——在最低五年随访依从性的多中心队列中实施更新的欧洲血管外科学会腹主动脉瘤腔内修复术后监测算法:通过一年期瘤囊动态变化进一步改善结果

Editor's Choice - Implementation of the Updated European Society for Vascular Surgery Proposed Endovascular Aneurysm Repair Surveillance Algorithm in a Multicentre Cohort with a Minimum Five Year Follow Up Adherence: Further Improvement of Results via One Year Sac Dynamics.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-04-10

这项多中心回顾性观察研究纳入596例腹主动脉瘤腔内修复术后患者,验证更新版ESVS监测算法。50.3%患者符合低风险标准,低风险组五年破裂率0.7% vs 3%(p=0.031)、再干预率9.7% vs 17.2%(p=0.007)均较低。一年期瘤囊回缩且无内漏的低风险患者(占队列20.1%)五年改良算法潜在预测97.6%不良事件。

要点

  • 596例EVAR患者中300例(50.3%)符合ESVS低风险标准。
  • 低风险组五年破裂率0.7% vs 3%(p=0.031),再干预率9.7% vs 17.2%(p=0.007)。
  • 一年期瘤囊回缩且无内漏的低风险患者可考虑减少监测。

核心结论

  • 更新版ESVS监测算法能在五年随访内一致地预测潜在不良事件,但细化患者分层可能进一步改善结果。
  • 初始分类为低风险且一年期瘤囊回缩无内漏的患者可能是减少监测的候选者。

研究设计与样本

  • 多中心、回顾性、观察性研究,纳入四个高容量中心连续接受EVAR治疗腹主动脉瘤且随访依从性至少五年的患者。
  • 按ESVS定义将患者分为高风险和低风险不良事件组进行比较,并对低风险且一年期瘤囊回缩无内漏患者进行亚组分析。

主要发现

  • 596例符合纳入标准患者中300例(50.3%)符合ESVS低风险标准。
  • 五年随访时低风险组破裂率0.7% vs 高风险组3%(p=0.031),动脉瘤相关死亡率0.7% vs 2.4%(p=0.089),再干预率9.7% vs 17.2%(p=0.007)。
  • 初始五年随访期间84例患者发生不良事件(再干预、破裂和/或动脉瘤相关死亡),其中28例发生在ESVS低风险组,ESVS方案五年内预测低风险患者90.7%潜在不良事件的能力。
  • ESVS低风险且一年期随访瘤囊回缩无内漏患者(占总队列20.1%)亚组分析显示,五年改良ESVS方案潜在预测97.6%不良事件(记录3例再干预)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This multicentre, retrospective, observational study aimed to identify patients who are suitable for less frequent follow up (FU) checkups after endovascular aneurysm repair (EVAR) through the validation and implementation of the recently updated European Society for Vascular Surgery (ESVS) surveillance algorithm. METHODS: An analysis was performed on consecutive patients who underwent EVAR for abdominal aortic aneurysm (AAA) at four high volume centres that demonstrated adherence to FU for at least five years. Patients were divided into high and low risk of adverse event groups, according to ESVS definitions, and compared. A sub-analysis was conducted for patients categorised as low risk who exhibited sac regression and no evidence of endoleak at the one year FU assessment. RESULTS: Of 596 patients meeting the inclusion criteria, 300 (50.3%) fulfilled the ESVS criteria for classification as low risk. At the five year FU, the rates of rupture (0.7% vs. 3%; p = .031), AAA related death (0.7% vs. 2.4%; p = .089), and re-intervention (9.7% vs. 17.2%; p = .007) were lower in the low risk group. Over the initial five years of FU, 84 patients experienced adverse events such as re-interventions, ruptures, and or AAA related death, with 28 occurring in the ESVS low risk group, indicating that the ESVS protocol has a five year capability of predicting 90.7% of potential adverse events in low risk patients. The sub-analysis of ESVS low risk patients who exhibited sac regression and no evidence of endoleak at one year FU (20.1% of the total cohort) revealed a five year modified ESVS protocol capability of potentially predicting 97.6% of adverse events (three re-interventions recorded). CONCLUSION: The updated ESVS surveillance algorithm provides a consistent prediction of potential adverse events within five years of FU, although refining patient stratification may further improve outcomes. Patients initially classified as low risk and also exhibiting sac regression without endoleaks at one year could be candidates for reduced surveillance.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Esposito D, Melani C, Accarino G, et al. Editor's Choice - Implementation of the Updated European Society for Vascular Surgery Proposed Endovascular Aneurysm Repair Surveillance Algorithm in a Multicentre Cohort with a Minimum Five Year Follow Up Adherence: Further Improvement of Results via One Year Sac Dynamics. Eur J Vasc Endovasc Surg. 2025. PMID: 40216188. doi:10.1016/j.ejvs.2025.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。